Detalhe da pesquisa
1.
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs.
Breast Cancer Res Treat
; 198(3): 607-621, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847915
2.
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
Breast Cancer Res Treat
; 185(2): 281-292, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001337
3.
Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.
Breast Cancer Res Treat
; 181(2): 297-307, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277377
4.
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer.
Endocrinology
; 163(12)2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251879
5.
RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells.
Stem Cells
; 27(12): 3001-11, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19821493
6.
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer.
Cancers (Basel)
; 12(9)2020 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961773
7.
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds.
NPJ Breast Cancer
; 5: 45, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815181
8.
PD2/PAF1 at the Crossroads of the Cancer Network.
Cancer Res
; 78(2): 313-319, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311159
9.
Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@erGO) nanocomposite for selective detection of Parkinson's disease biomarker.
Biosens Bioelectron
; 115: 53-60, 2018 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29800831
10.
Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Oncotarget
; 7(3): 3317-31, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689992
11.
Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Oncotarget
; 6(37): 40295-309, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516699
12.
PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia.
Oncotarget
; 5(12): 4480-91, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947474
13.
Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.
Arch Pathol Lab Med
; 137(4): 546-51, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23544943
14.
Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis.
Clin Cancer Res
; 18(22): 6188-98, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22977192
15.
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
J Hematol Oncol
; 5: 68, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23102107
16.
MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells.
J Ovarian Res
; 4(1): 7, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21521521
17.
Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer.
PLoS One
; 6(10): e26926, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22046413
18.
Human PAF complexes in endocrine tumors and pancreatic cancer.
Expert Rev Endocrinol Metab
; 3(5): 557-565, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290411